Product News: Health, Medical and Dental Supplies & Equipment
Plasma Sample Collection Cards enable lab-free preparation.
Press Release Summary:
May 2, 2014 - Allowing plasma generation from finger-stick, Noviplex™ Cards accelerate analysis and simplify blood collection for laboratory and medical professionals by eliminating phlebotomy, syringes, and glass collection tubes. Collection of volumetric sample of plasma can be done within minutes, and plasma can be generated from specimen volumes from 20–75 µL of whole blood. Suited for use with LC-MS/MS analysis, cards offer single-step, solid-phase method for sample preparation and analyte extraction.
Original Press Release
Shimadzu Introduces Noviplex Cards for Accelerated Blood Plasma Collection and Disease Analysis
Press release date: April 22, 2014
Noviplex Cards offer significant advantages for laboratory and medical professionals, accelerating analysis and simplifying blood collection by eliminating the need for phlebotomy, syringes and glass collection tubes.
“Noviplex technology enables lab-free sample preparation, and the convenient ‘lab-on-a-card’ format rapidly generates plasma for LC-MS/MS analysis,” said Scott Kuzdzal, PhD, life science business unit manager at SSI. “This will greatly simplify collection and processing in medical clinics, labs and hospitals.”
Shimadzu partnered with Novilytic Laboratories to offer Noviplex Cards. The technology allows plasma generation from a finger-stick as opposed to traditional methods of blood collection and preparation. Plasma can be generated from specimen volumes ranging from 20 to 75 µL of whole blood. The technology offers a single-step, solid-phase method for sample preparation and analyte extraction. Noviplex accelerates processes by eliminating refrigeration, centrifugation solvent extraction and evaporation.
“Next-generation Novilytic Laboratory advances in sample collection and preparation vastly accelerate disease marker analysis and enable a paradigm change in clinical chemistry, wellness monitoring and medicine,” said Fred Regnier, PhD, Professor Emeritus, John H. Law Distinguished Professor of Chemistry, Purdue University, and a co-founder of Novilytic Laboratories.
Noviplex also provides exceptional reproducibility independent of hematocrit, 99 percent removal of red blood cells, and rapid sample preparation for MS-based analysis while maintaining assay reproducibility and selectivity.
For an overview and demonstration of the Noviplex Cards and technology, visit www.DriedPlasmaSpots.com.
About Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit www.ssi.shimadzu.com for more information.